First Time Loading...

Avanos Medical Inc
NYSE:AVNS

Watchlist Manager
Avanos Medical Inc Logo
Avanos Medical Inc
NYSE:AVNS
Watchlist
Price: 18.1 USD 1.4% Market Closed
Updated: Apr 28, 2024
Section:
 

Wall Street
Price Targets

AVNS Price Targets Summary
Avanos Medical Inc

Wall Street analysts forecast AVNS stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for AVNS is 23.97 USD with a low forecast of 20.2 USD and a high forecast of 28.35 USD.

AVNS Lowest Forecast
Wall Street Target
20.2 USD
12% Upside
AVNS Average Forecast
Wall Street Target
23.97 USD
32% Upside
AVNS Highest Forecast
Wall Street Target
28.35 USD
57% Upside
Lowest
Price Target
20.2 USD
12% Upside
Average
Price Target
23.97 USD
32% Upside
Highest
Price Target
28.35 USD
57% Upside
Avanos Medical Inc Competitors:
Price Targets
J
OMED
Jayamas Medica Industri TBK PT
13% Upside
S
600529
Shandong Pharmaceutical Glass Co Ltd
23% Upside
COO
Cooper Companies Inc
24% Upside
H
3593
Hogy Medical Co Ltd
2% Downside
J
OMED
Jayamas Medica Industri TBK PT
13% Upside
S
600529
Shandong Pharmaceutical Glass Co Ltd
23% Upside
COO
Cooper Companies Inc
24% Upside
H
3593
Hogy Medical Co Ltd
2% Downside
ESTA
Establishment Labs Holdings Inc
27% Upside
SILK
Silk Road Medical Inc
16% Upside
S
1501
Shanghai Kindly Medical Instruments Co Ltd
30% Upside
XVIVO
Xvivo Perfusion AB
5% Upside

Revenue
Forecast

Revenue Estimate
Avanos Medical Inc

For the last 8 years the compound annual growth rate for Avanos Medical Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

4%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Avanos Medical Inc

The compound annual growth rate of Avanos Medical Inc's operating income for the next 3 years is 225%.

N/A
Past Growth
225%
Estimated Growth
Estimates Accuracy
-62%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Avanos Medical Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-30%
Average Miss
What are analyst estimates?

See Also

Summary
AVNS intrinsic value, competitors valuation, and company profile.
DCF Valuation
AVNS stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AVNS stock valuation using valuation multiples.
Wall Street Estimates
AVNS price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AVNS stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is AVNS's stock price target?
Price Target
23.97 USD

According to Wall Street analysts, the average 1-year price target for AVNS is 23.97 USD with a low forecast of 20.2 USD and a high forecast of 28.35 USD.

What is Avanos Medical Inc's Revenue forecast?
Projected CAGR
5%

For the last 8 years the compound annual growth rate for Avanos Medical Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

What is Avanos Medical Inc's Operating Income forecast?
Projected CAGR
225%

The compound annual growth rate of Avanos Medical Inc's operating income for the next 3 years is 225%.

ALPHA SPREAD
Join more than 132,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.